Literature DB >> 20695431

Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.

R James Christie1, Diana J Anderson, David W Grainger.   

Abstract

Reversible covalent conjugation chemistries that allow site- and condition-specific coupling and uncoupling reactions are attractive components in nanotechnologies, bioconjugation methods, imaging, and drug delivery systems. Here, we compare three heterobifunctional cross-linkers, containing both thiol- and amine-reactive chemistries, to form pH-labile hydrazones with hydrazide derivatives of the known and often published water-soluble polymer, poly[N-(2-hydroxypropyl methacrylamide)] (pHPMA), while subsequently coupling thiol-containing molecules to the cross-linker via maleimide addition. Two novel cross-linkers were prepared from the popular heterobifunctional cross-linking agent, succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC), modified to contain either terminal aldehyde groups (i.e., 1-(N-3-propanal)-4-(N-maleimidomethyl) cyclohexane carboxamide, PMCA) or methylketone groups (i.e., 1-(N-3-butanone)-4-(N-maleimidomethyl) cyclohexane carboxamide, BMCA). A third cross-linking agent was the commercially available N-4-acetylphenyl maleimide (APM). PMCA and BMCA exhibited excellent reactivity toward hydrazide-derivatized pHPMA with essentially complete hydrazone conjugation to polymer reactive sites, while APM coupled only ∼60% of available reactive sites on the polymer despite a 3-fold molar excess relative to polymer hydrazide groups. All polymer hydrazone conjugates bearing these bifunctional agents were then further reacted with thiol-modified tetramethylrhodamine dye, confirming cross-linker maleimide reactivity after initial hydrazone polymer conjugation. Incubation of dye-labeled polymer conjugates in phosphate buffered saline at 37 °C showed that hydrazone coupling resulting from APM exhibited the greatest difference in stability between pH 7.4 and 5.0, with hydrolysis and dye release increased at pH 5.0 over a 24 h incubation period. Polymer conjugates bearing hydrazones formed from cross-linker BMCA exhibited intermediate stability with hydrolysis much greater at pH 5.0 at early time points, but hydrolysis at pH 7.4 was significant after 5 h. Hydrazones formed with the PMCA cross-linker showed no difference in release rates at pH 7.4 and 5.0.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20695431      PMCID: PMC2958219          DOI: 10.1021/bc100049c

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  34 in total

Review 1.  Endosomes, lysosomes: their implication in gene transfer.

Authors:  R Wattiaux; N Laurent; S Wattiaux-De Coninck; M Jadot
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

Review 2.  Drug-polymer conjugates containing acid-cleavable bonds.

Authors:  F Kratz; U Beyer; M T Schütte
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

3.  Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.

Authors:  P C Rodrigues; U Beyer; P Schumacher; T Roth; H H Fiebig; C Unger; L Messori; P Orioli; D H Paper; R Mülhaupt; F Kratz
Journal:  Bioorg Med Chem       Date:  1999-11       Impact factor: 3.641

4.  A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry.

Authors:  E B Getz; M Xiao; T Chakrabarty; R Cooke; P R Selvin
Journal:  Anal Biochem       Date:  1999-08-15       Impact factor: 3.365

Review 5.  Water soluble polymers in tumor targeted delivery.

Authors:  J Kopecek; P Kopecková; T Minko; Z R Lu; C M Peterson
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

6.  Reaction of Tris(2-carboxyethyl)phosphine (TCEP) with maleimide and alpha-haloacyl groups: anomalous elution of TCEP by gel filtration.

Authors:  D E Shafer; J K Inman; A Lees
Journal:  Anal Biochem       Date:  2000-06-15       Impact factor: 3.365

7.  Development of potent monoclonal antibody auristatin conjugates for cancer therapy.

Authors:  Svetlana O Doronina; Brian E Toki; Michael Y Torgov; Brian A Mendelsohn; Charles G Cerveny; Dana F Chace; Ron L DeBlanc; R Patrick Gearing; Tim D Bovee; Clay B Siegall; Joseph A Francisco; Alan F Wahl; Damon L Meyer; Peter D Senter
Journal:  Nat Biotechnol       Date:  2003-06-01       Impact factor: 54.908

8.  Optimizing the reversibility of hydrazone formation for dynamic combinatorial chemistry.

Authors:  Régis Nguyen; Ivan Huc
Journal:  Chem Commun (Camb)       Date:  2003-04-21       Impact factor: 6.222

Review 9.  Reversible covalent chemistry in drug delivery.

Authors:  Kevin R West; Sijbren Otto
Journal:  Curr Drug Discov Technol       Date:  2005-09

10.  PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.

Authors:  R Satchi; T A Connors; R Duncan
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

View more
  5 in total

1.  Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Authors:  Guangchang Zhou; Faraz Khan; Qing Dai; Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Biosyst       Date:  2012-07-06

2.  Synthesis: Click chemistry gets reversible.

Authors:  David A Fulton
Journal:  Nat Chem       Date:  2016-09-22       Impact factor: 24.427

Review 3.  pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Bioengineering (Basel)       Date:  2017-01-18

4.  The Development of a Macromolecular Analgesic for Arthritic Pain.

Authors:  Laura Weber; Xiaobei Wang; Rongguo Ren; Xin Wei; Gang Zhao; Junxiao Yang; Hongjiang Yuan; Huiling Pang; Hanjun Wang; Dong Wang
Journal:  Mol Pharm       Date:  2019-02-14       Impact factor: 4.939

5.  Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.

Authors:  Bai Xiang; Xue-Li Jia; Jin-Long Qi; Li-Ping Yang; Wei-Hong Sun; Xiao Yan; Shao-Kun Yang; De-Ying Cao; Qing Du; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2017-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.